Detalhe da pesquisa
1.
The Efficacy of Immune Checkpoint Inhibitors in Microsatellite Stable Colorectal Cancer: A Systematic Review.
Oncologist
; 29(5): e580-e600, 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38309719
2.
The association between HER2-low status and survival in patients with metastatic breast cancer treated with Cyclin-dependent kinases 4 and 6 inhibitors: a systematic review and meta-analysis.
Breast Cancer Res Treat
; 204(3): 443-452, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38240935
3.
Sacituzumab govitecan vs. chemotherapy for metastatic breast cancer: a meta-analysis on safety outcomes.
Future Oncol
; : 1-8, 2024 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38864297
4.
Efficacy and safety of bevacizumab in patients with low-grade serous ovarian cancer.
Future Oncol
; 20(4): 207-214, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38328890
5.
Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy.
Int J Clin Oncol
; 29(6): 822-831, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38565751
6.
The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study.
Int J Clin Oncol
; 29(3): 258-265, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38310597
7.
Sirolimus experience in adult patients with vascular malformations.
Vascular
; : 17085381241241853, 2024 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38523367
8.
Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG).
Eur Arch Otorhinolaryngol
; 2024 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38795147
9.
Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy.
Int J Cancer
; 152(4): 679-685, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36082448
10.
Comparison of PD-L1 and VISTA expression status in primary and recurrent/refractory tissue after (chemo)radiotherapy in head and neck cancer.
Strahlenther Onkol
; 199(8): 761-772, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36862156
11.
A chance in hopeless cancer: 5-year complete remission after oxaliplatin-based therapy in a patient with BRCA2 mutant metastatic pancreatic cancer.
Anticancer Drugs
; 34(10): 1190-1192, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36729128
12.
The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors.
Anticancer Drugs
; 34(6): 783-790, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36729111
13.
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer.
Future Oncol
; 19(10): 727-736, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37133230
14.
Immune checkpoint inhibitor-related hearing loss: a systematic review and analysis of individual patient data.
Support Care Cancer
; 31(12): 624, 2023 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37819422
15.
Role of sarcopenia on survival and treatment-related toxicity in head and neck cancer: a narrative review of current evidence and future perspectives.
Eur Arch Otorhinolaryngol
; 280(8): 3541-3556, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37188907
16.
The association between pan-immune-inflammation value and survival in head and neck squamous cell carcinoma.
Eur Arch Otorhinolaryngol
; 280(5): 2471-2478, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36565325
17.
Does docetaxel matter in metastatic gastric cancer? FOLFOX versus FLOT regimens as first-line treatment.
Anticancer Drugs
; 33(1): e477-e485, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34261917
18.
The benefit of immunotherapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
Future Oncol
; 2022 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36533987
19.
Adjuvant treatment with paclitaxel plus trastuzumab for node-negative breast cancer: real-life experience.
Future Oncol
; 18(3): 323-331, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34758639
20.
Infectious complications of cyclin-dependent kinases 4 and 6 inhibitors in patients with hormone-receptor-positive metastatic breast cancer: a systematic review and meta-analysis.
Support Care Cancer
; 30(11): 9071-9078, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35972646